Augmedix (AUGX) Stock Price, News & Analysis

Company Overview

Augmedix is a healthcare technology company that specializes in providing real‐time clinical documentation solutions for physicians. Using a combination of cloud-based software and specially trained remote medical scribes, the company captures and converts physician-patient encounters into structured electronic health records (EHR) notes. This service is designed to streamline workflow, reduce administrative burden for clinicians and allow more time for direct patient care.

The company’s core offering revolves around its Augmedix Platform, which integrates with leading EHR systems to deliver seamless data capture. Through secure audio and video streaming, remote scribes listen in on live patient visits and populate clinical documentation in real time. Augmedix also offers complementary tools such as mobile and tablet applications that enable on-the-go access to patient records, telehealth support and analytics dashboards for practice performance monitoring.

Founded in 2012 and headquartered in San Francisco, Augmedix was an early adopter of wearable technology, initially leveraging devices like Google Glass to facilitate doctor-scribe interactions. Co-founders Ian Shakil (who serves as Chief Executive Officer) and Pelu Tran (Chief Operating Officer) have guided the company’s expansion into multiple U.S. states as well as international markets, including the United Kingdom and Canada. The leadership team comprises professionals with deep experience in healthcare operations, technology development and clinical workflow optimization.

Augmedix partners with hospitals, health systems and private practices to tailor its documentation services to specific specialties, such as primary care, orthopedics and neurology. By outsourcing the clerical aspects of patient visits, the company helps reduce physician burnout, enhance documentation accuracy and improve patient satisfaction — all while enabling practices to leverage data insights for better operational decision-making.

Key Stats

• Today's Range: $2.35 to $2.35
• 50-Day Range: $2.35 to $2.35
• 52-Week Range: $0.73 to $6.25
• Volume: N/A
• Average Volume: 635,746 shs
• Market Capitalization: $115.07 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 3/27/2023
• Today: 5/19/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:AUGX
• CIK: 1769804
• Web: www.augmedix.com
• Phone: 888-669-4885
• Fax: N/A
• Employees: 710
• Year Founded: 2012

Profitability

• EPS (Trailing Twelve Months): ($0.43)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$24.45 million
• Net Margins: -57.70%
• Pretax Margin: -57.23%
• Return on Equity: -980.09%
• Return on Assets: -57.85%

Debt

• Debt-to-Equity Ratio: 3.74
• Current Ratio: 1.70
• Quick Ratio: 1.70

Sales & Book Value

• Annual Sales: $51.58 million
• Price / Sales: 2.23
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.10 per share
• Price / Book: 23.50

Miscellaneous

• Outstanding Shares: 48,968,000
• Free Float: 36,316,000
• Market Cap: $115.07 million
• Optionable: Not Optionable
• Beta: -0.22